ARCHIVES

Lenalidomide, An Altered Thalidomide, Shows Promise

This article is from The Cancer Letter archive.

Vol. 29 No. 11 | November 24, 2006

Download PDF Visit The Full Archive

Related Articles

NCI Sets Initial R01 Payline At 18th Percentile Under CR.

November 24, 2000

Arizona Cancer Center Seeks NCI Recognition As Comprehensive

May 29, 1987

Stand Up To Cancer Launches Immunology “Dream Team”

December 14, 2012

In Brief: Biomedical Panel Report Will Support Cancer Program, Targeted Research

January 16, 1976

In Brief: William Roper To Head Health Research Center; Announcement Of New NIH director Is Imminent

July 2, 1993

DCCP Board Gives Concept Approval to Noncompeting Contracts

June 17, 1983